BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND LRP1B, ENSG00000168702, 53353, Q9NZR2, LRPDIT, LRP-DIT
11 results:

  • 1. Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real-world clinical tumor sequencing study.
    Huang Y; Qiu Y; Ding L; Ren S; Jiang Y; Luo J; Huang J; Yin X; Fu S; Zhao J; Hu K; Liao J
    J Pathol Clin Res; 2024 Mar; 10(2):e12367. PubMed ID: 38504382
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Co-Mutation of FAT3 and lrp1b in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy.
    Zhu M; Zhang L; Cui H; Zhao Q; Wang H; Zhai B; Jiang R; Jiang Z
    Front Immunol; 2021; 12():800951. PubMed ID: 35069585
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
    Yu Y; Xie Z; Zhao M; Lian X
    BMC Cancer; 2021 Apr; 21(1):368. PubMed ID: 33827485
    [TBL] [Abstract] [Full Text] [Related]  

  • 4.
    Brown LC; Tucker MD; Sedhom R; Schwartz EB; Zhu J; Kao C; Labriola MK; Gupta RT; Marin D; Wu Y; Gupta S; Zhang T; Harrison MR; George DJ; Alva A; Antonarakis ES; Armstrong AJ
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33653800
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nuclear localization of LDL receptor-related protein 1B in mammary gland carcinogenesis.
    Asano Y; Takeuchi T; Okubo H; Saigo C; Kito Y; Iwata Y; Futamura M; Yoshida K
    J Mol Med (Berl); 2019 Feb; 97(2):257-268. PubMed ID: 30607440
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Single nucleotide variant profiles of viable single circulating tumour cells reveal CTC behaviours in breast cancer.
    Wang Y; Guo L; Feng L; Zhang W; Xiao T; Di X; Chen G; Zhang K
    Oncol Rep; 2018 May; 39(5):2147-2159. PubMed ID: 29565466
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comprehensive somatic genome alterations of urachal carcinoma.
    Lee S; Lee J; Sim SH; Lee Y; Moon KC; Lee C; Park WY; Kim NK; Lee SH; Lee H
    J Med Genet; 2017 Aug; 54(8):572-578. PubMed ID: 28348108
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mutation Profiling of Usual Ductal Hyperplasia of the breast Reveals Activating Mutations Predominantly at Different Levels of the PI3K/AKT/mTOR Pathway.
    Jahn SW; Kashofer K; Thüringer A; Abete L; Winter E; Eidenhammer S; Viertler C; Tavassoli F; Moinfar F
    Am J Pathol; 2016 Jan; 186(1):15-23. PubMed ID: 26718977
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities.
    Craig DW; O'Shaughnessy JA; Kiefer JA; Aldrich J; Sinari S; Moses TM; Wong S; Dinh J; Christoforides A; Blum JL; Aitelli CL; Osborne CR; Izatt T; Kurdoglu A; Baker A; Koeman J; Barbacioru C; Sakarya O; De La Vega FM; Siddiqui A; Hoang L; Billings PR; Salhia B; Tolcher AW; Trent JM; Mousses S; Von Hoff D; Carpten JD
    Mol Cancer Ther; 2013 Jan; 12(1):104-16. PubMed ID: 23171949
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Somatic structural rearrangements in genetically engineered mouse mammary tumors.
    Varela I; Klijn C; Stephens PJ; Mudie LJ; Stebbings L; Galappaththige D; van der Gulden H; Schut E; Klarenbeek S; Campbell PJ; Wessels LF; Stratton MR; Jonkers J; Futreal PA; Adams DJ
    Genome Biol; 2010; 11(10):R100. PubMed ID: 20942901
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.
    Kadota M; Yang HH; Gomez B; Sato M; Clifford RJ; Meerzaman D; Dunn BK; Wakefield LM; Lee MP
    PLoS One; 2010 Feb; 5(2):e9201. PubMed ID: 20169162
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.